Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome
Clinical trial NCT05482464 · COMPLETED
Trial details
- NCT number
- NCT05482464
- Sponsor
- Oregon State University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.